Hasmik Keshishian

8.4k citations

31 papers · 2.5k indexed · 1 hit paper · h-index 20

Spectroscopy top 0.5%
- Advanced Proteomics Techniques and Applications 11
- Mass Spectrometry Techniques and Applications 9
- Analytical Chemistry and Chromatography 3
Molecular Biology top 5%
- Protein Degradation and Inhibitors 4
- Metabolomics and Mass Spectrometry Studies 3
- Glycosylation and Glycoproteins Research 2
- Protein purification and stability 2
Cancer Research top 10%
Immunology top 10%
Radiology, Nuclear Medicine and Imaging top 10%
- Monoclonal and Polyclonal Antibodies Research 3

Co-authors: Steven A. Carr Michael Burgess Eric Kuhn Terri A. Addona D.R. Mani Michael A. Gillette Robert E. Gerszten Marc S. Sabatine
Cited by: Spectroscopy Molecular Biology Cancer Research
Journals: Circulation (1 paper)Blood (1 paper)Nature Biotechnology (1 paper)
Partner nations: United States South Korea Germany

In The Last Decade

Hasmik Keshishian

29 papers receiving 2.4k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Hasmik Keshishian

Since Specialization

Citations

This map shows the geographic impact of Hasmik Keshishian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hasmik Keshishian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hasmik Keshishian more than expected).

Fields of papers citing papers by Hasmik Keshishian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hasmik Keshishian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hasmik Keshishian. The network helps show where Hasmik Keshishian may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hasmik Keshishian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hasmik Keshishian Line = papers co-authored together Hasmik Keshishian links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Spatially resolved translational dysregulation in Grin2a +/- mouse model of schizophrenia bioRxiv (Cold Spring Harbor Laboratory) ·Mingrui Wu,Jiahao Huang,Sameer Aryal,Zohreh Farsi,Hongyu Chen,Yuan Zhou,Shuchen Luo,Wendy Xueyi Wang,Kevin Bonanno,Margaret Yin,Inès Picard,Borislav Dejanovic,Hasmik Keshishian,Steven A. Carr,Morgan Sheng,Xiao Wang	2025	1
2	Abstract A037: Mechanisms of resistance to BAY 2927088, the first reversible inhibitor targeting EGFR exon 20 insertion mutations in non-small cell lung cancer Molecular Cancer Therapeutics ·Gizem Karsli Uzunbas,Quinn McVeigh,Akansha Gupta,Stephanie Hoyt,Kristen Doucette,Hasmik Keshishian,Steven A. Carr,Xiaoping Yang,David E. Root,Andrew D. Cherniack,Franziska Siegel,Stephan Siegel,Matthew Meyerson,Heidi Greulich	2023	0
3	Deep proteomics identifies shared molecular pathway alterations in synapses of patients with schizophrenia and bipolar disorder and mouse model Cell Reports ·Sameer Aryal,Kevin Bonanno,Bryan J. Song,D.R. Mani,Hasmik Keshishian,Steven A. Carr,Morgan Sheng,Borislav Dejanovic	2023	29
4	TAILS Identifies Candidate Substrates and Biomarkers of ADAMTS7, a Therapeutic Protease Target in Coronary Artery Disease Molecular & Cellular Proteomics ·Bryan T. MacDonald,Hasmik Keshishian,Charles C. Mundorff,Alessandro Arduini,Daniel Lai,Kayla J. Bendinelli,Nicholas R. Popp,Bidur Bhandary,Karl R. Clauser,Harrison Specht,Nadine H. Elowe,Dylan Laprise,Yi Xing,Virendar K. Kaushik,Steven A. Carr,Patrick T. Ellinor	2022	10
5	MEDB-85. Transcriptional complexes as resistance drivers to BET inhibition Neuro-Oncology ·Adam N. Boynton,Leslie Lupien,Rushil Kumbhani,Gabrielle Gionet,Madison S. Chacon,Amy Goodale,David E. Root,Hasmik Keshishian,Margaret Lea Robinson,Steven A. Carr,Pratiti Bandopadhayay	2022	0
6	Optimized Liquid and Gas Phase Fractionation Increases HLA-Peptidome Coverage for Primary Cell and Tissue Samples Molecular & Cellular Proteomics ·Susan Klaeger,Annie Apffel,Karl R. Clauser,Siranush Sarkizova,Giacomo Oliveira,Suzanna Rachimi,Phuong M. Le,Anna Tarren,Vipheaviny Chea,Jennifer G. Abelin,David A. Braun,Patrick A. Ott,Hasmik Keshishian,Nir Hacohen,Derin B. Keskin,Catherine J. Wu,Steven A. Carr	2021	32
7	The Conserved Translation Factor LepA Is Required for Optimal Synthesis of a Porin Family in Mycobacterium smegmatis Journal of Bacteriology ·Skye R. S. Fishbein,Francesca G. Tomasi,Ian D. Wolf,Charles L. Dulberger,Albert Wang,Hasmik Keshishian,Luke Wallace,Steven A. Carr,Thomas R. Ioerger,E. Hesper Rego,Eric J. Rubin	2020	10
8	A Curated Resource for Phosphosite-specific Signature Analysis Molecular & Cellular Proteomics ·Karsten Krug,Philipp Mertins,Bin Zhang,Peter Hornbeck,Rajesh Raju,Rushdy Ahmad,Matthew J. Szucs,Filip Mundt,Dominique Forestier,Judit Jané‐Valbuena,Hasmik Keshishian,Michael A. Gillette,Pablo Tamayo,Jill P. Mesirov,Jacob D. Jaffe,StevenA. Carr,D.R. Mani	2018	165
9	Quantitative, multiplexed workflow for deep analysis of human blood plasma and biomarker discovery by mass spectrometry Nature Protocols ·Hasmik Keshishian,Michael Burgess,Harrison Specht,Luke Wallace,Karl R. Clauser,Michael A. Gillette,Steven A. Carr	2017	125
10	New Guidelines for Publication of Manuscripts Describing Development and Application of Targeted Mass Spectrometry Measurements of Peptides and Proteins Molecular & Cellular Proteomics ·Susan E. Abbatiello,Bradley L. Ackermann,Christoph H. Borchers,Ralph Bradshaw,Steven A. Carr,Robert J. Chalkley,Meena Choi,Eric W. Deutsch,Bruno Domon,Andrew N. Hoofnagle,Hasmik Keshishian,Eric Kuhn,D.C. Liebler,Michael J. MacCoss,Brendan MacLean,D.R. Mani,Hendrik Neubert,Derek Smith,Olga Vitek,Lisa J. Zimmerman	2017	29
11	Multiplexed, Quantitative Workflow for Sensitive Biomarker Discovery in Plasma Yields Novel Candidates for Early Myocardial Injury Molecular & Cellular Proteomics ·Hasmik Keshishian,Michael Burgess,Michael A. Gillette,Philipp Mertins,Karl R. Clauser,D.R. Mani,Eric Kuhn,Laurie Farrell,Robert E. Gerszten,Steven A. Carr	2015	158
12	Quantitative proteomics suggests decrease in the secretogranin‐1 cerebrospinal fluid levels during the disease course of multiple sclerosis PROTEOMICS ·Ann Cathrine Kroksveen,Jacob D. Jaffe,Elise Aasebø,Harald Barsnes,Yngvild Bjørlykke,Diego Franciotta,Hasmik Keshishian,Kjell‐Morten Myhr,Jill A. Opsahl,Vincent Van Pesch,Charlotte E. Teunissen,Øivind Torkildsen,Rune J. Ulvik,Heidrun Vethe,Steven A. Carr,Frode S. Berven	2015	28
13	Simplified and Efficient Quantification of Low-abundance Proteins at Very High Multiplex via Targeted Mass Spectrometry Molecular & Cellular Proteomics ·Michael Burgess,Hasmik Keshishian,D.R. Mani,Michael A. Gillette,Steven A. Carr	2014	55
14	A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease Nature Biotechnology ·Terri A. Addona,Xu Shi,Hasmik Keshishian,D.R. Mani,Michael Burgess,Michael A. Gillette,Karl R. Clauser,Dongxiao Shen,Gregory D. Lewis,Laurie Farrell,Michael A. Fifer,Marc S. Sabatine,Robert E. Gerszten,Steven A. Carr	2011	192
15	Rictor Phosphorylation on the Thr-1135 Site Does Not Require Mammalian Target of Rapamycin Complex 2 Molecular Cancer Research ·Delphine R. Boulbés,Chien-Hung Chen,Tattym E. Shaiken,Nitin Agarwal,Timothy R. Peterson,Terri A. Addona,Hasmik Keshishian,Steven A. Carr,Mark A. Magnuson,David M. Sabatini,Dos D. Sarbassov	2010	57
16	Quantification of Cardiovascular Biomarkers in Patient Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution Molecular & Cellular Proteomics ·Hasmik Keshishian,Terri A. Addona,Michael Burgess,D.R. Mani,Xu Shi,Eric Kuhn,Marc S. Sabatine,Robert E. Gerszten,Steven A. Carr	2009	233
17	Developing Multiplexed Assays for Troponin I and Interleukin-33 in Plasma by Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry Clinical Chemistry ·Eric Kuhn,Terri A. Addona,Hasmik Keshishian,Michael Burgess,D.R. Mani,Richard Lee,Marc S. Sabatine,Robert E. Gerszten,Steven A. Carr	2009	197
18	Accurate Inclusion Mass Screening Molecular & Cellular Proteomics ·Jacob D. Jaffe,Hasmik Keshishian,Betty Chang,Theresa A. Addona,Michael A. Gillette,Steven A. Carr	2008	121
19	Regulation of IRAK-4 kinase activity via autophosphorylation within its activation loop Biochemical and Biophysical Research Communications ·Hong Cheng,Terri A. Addona,Hasmik Keshishian,Erik N. Dahlstrand,Chafen Lu,Marion Dorsch,Zhi Li,Anlai Wang,Timothy D. Ocain,Ping Li,Thomas F. Parsons,Bruce Jaffee,Yajun Xu	2006	61
20	Peptides as affinity surfaces for protein purification Journal of Molecular Recognition ·Aruna Pingali,Brian McGuinness,Hasmik Keshishian,Jing Fei-Wu,L. Varady,Fred E. Regnier	1996	12

About Hasmik Keshishian

Hasmik Keshishian is a scholar working on Spectroscopy, Biological Psychiatry and Molecular Biology, having authored 31 papers that have together received 2.5k indexed citations. Recurring topics across this work include Advanced Proteomics Techniques and Applications (11 papers), Mass Spectrometry Techniques and Applications (9 papers), Protein Degradation and Inhibitors (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Analytical Chemistry and Chromatography (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Protein purification and stability (2 papers). The work is most often cited by research in Spectroscopy (1.4k citations), Molecular Biology (1.6k citations) and Cancer Research (174 citations). Hasmik Keshishian has collaborated with scholars based in United States, South Korea and Germany. Frequent co-authors include Steven A. Carr, Michael Burgess, Eric Kuhn, Terri A. Addona, D.R. Mani, Michael A. Gillette, Robert E. Gerszten, Marc S. Sabatine, Karl R. Clauser and Xu Shi. Their work appears in journals such as Circulation, Blood and Nature Biotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact